ProfileGDS4132 / 215191_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 29% 37% 35% 28% 31% 30% 32% 38% 35% 31% 41% 35% 39% 36% 41% 38% 49% 50% 35% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10185.746134
GSM201543Muscle PCOS pioglitazone 12161.164629
GSM201544Muscle PCOS pioglitazone 16196.362537
GSM201545Muscle PCOS pioglitazone 20196.815135
GSM201829Muscle PCOS pioglitazone 23173.903928
GSM201830Muscle PCOS pioglitazon 25178.881731
GSM201831Muscle PCOS pioglitazone 27172.796930
GSM201832Muscle PCOS pioglitazone 3180.318132
GSM201833Muscle PCOS pioglitazone 4190.189738
GSM201834Muscle PCOS pioglitazone 8186.576735
GSM201835Muscle PCOS after pioglitazone 10264.263931
GSM201836Muscle PCOS after pioglitazone 12295.451541
GSM201837Muscle PCOS after pioglitazone 16273.722535
GSM201838Muscle PCOS after pioglitazone 20291.04639
GSM201839Muscle PCOS after pioglitazone 23283.482536
GSM201840Muscle PCOS after pioglitazone 252103.43141
GSM201841Muscle PCOS after pioglitazone 27283.5338
GSM201842Muscle PCOS after pioglitazone 32109.1249
GSM201843Muscle PCOS after pioglitazone 42127.41950
GSM201844Muscle PCOS after pioglitazone 8284.150335